trending Market Intelligence /marketintelligence/en/news-insights/trending/Z0ovWqb7Oji1AT749kfznw2 content esgSubNav
In This List

Suda proposes 25-to-1 share consolidation to address price volatility

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Suda proposes 25-to-1 share consolidation to address price volatility

Suda Pharmaceuticals Ltd. is proposing a 25-to-1 consolidation of its shares to mitigate certain share price issues.

If shareholders approve the consolidation at the company's general meeting on Nov. 12, the issued shares in Suda will decrease to about 142 million shares from about 3.6 billion shares. Following approval, options will also be reorganized and consolidated in the same ratio.

The exercise price of the options will also be adjusted in inverse proportion to the consolidation's ratio.

Suda Pharmaceuticals is a drug delivery company focusing on oro-mucosal administration.